» Articles » PMID: 37899806

State-of-the-art Prostate Imaging

Overview
Specialty General Medicine
Date 2023 Oct 30
PMID 37899806
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer is one of the most common cancers in men. In addition to methods such as prostate-specific antigen test, digital rectal examination, and transrectal ultrasonography, magnetic resonance imaging has an important role for accurate and reproducible diagnosis. However, guidance in targeted biopsies and recent use in determining localization for treatment increase its importance. Due to technical difficulties, patient tolerance, and differences in interpretation, the prostate imaging reporting and data system recommends preparations for the patient and magnetic resonance imaging techniques. However, techniques continue to be developed to improve the diagnosis rate and image quality. In our article, patient preparation before imaging and techniques were tried to be discussed in detail. In addition, current approaches in biparametric magnetic resonance imaging and radiomics and new techniques such as T1 and T2 mapping will be mentioned.

References
1.
Rosenkrantz A, Parikh N, Kierans A, Kong M, Babb J, Taneja S . Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go?. Acad Radiol. 2016; 23(6):704-11. DOI: 10.1016/j.acra.2016.02.003. View

2.
Sharif-Afshar A, Feng T, Koopman S, Nguyen C, Li Q, Shkolyar E . Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging. Can J Urol. 2015; 22(2):7698-702. View

3.
Toivonen J, Merisaari H, Pesola M, Taimen P, Bostrom P, Pahikkala T . Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm(2) : correlation with Gleason score and repeatability of region of interest analysis. Magn Reson Med. 2014; 74(4):1116-24. DOI: 10.1002/mrm.25482. View

4.
Ahmed H, El-Shater Bosaily A, Brown L, Gabe R, Kaplan R, Parmar M . Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815-822. DOI: 10.1016/S0140-6736(16)32401-1. View

5.
Tamada T, Sone T, Jo Y, Yamamoto A, Yamashita T, Egashira N . Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology. 2008; 248(2):531-9. DOI: 10.1148/radiol.2482070157. View